Request Demo
Last update 13 Dec 2025
SYH2070
Last update 13 Dec 2025
Overview
Basic Info
Drug Type siRNA |
Synonyms SYH2070 |
Target |
Action inhibitors |
Mechanism ANGPTL3 inhibitors(Angiopoietin like 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Boost your research with our RNA technology data.
login
or
Related
1
Clinical Trials associated with SYH2070NCT07241923
A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SYH2070 Injection in Healthy Subjects
100 Clinical Results associated with SYH2070
Login to view more data
100 Translational Medicine associated with SYH2070
Login to view more data
100 Patents (Medical) associated with SYH2070
Login to view more data
100 Deals associated with SYH2070
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hyperlipidemias | Phase 1 | China | 15 Nov 2025 | |
| Hyperlipidemias | Phase 1 | China | 15 Nov 2025 | |
| Hyperlipidemia, Familial Combined | IND Approval | China | 30 Sep 2025 | |
| Hypertriglyceridemia | IND Approval | China | 30 Sep 2025 | |
| Endocrine System Diseases | Preclinical | China | 01 Mar 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free